This NDC is on FDA's drug shortage list (posted Apr 7, 2020)
Reported reason: Other
Product Information
FUROSEMIDE 40 MG/4 ML VIAL is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.2658 per ML under NDC 23155047342. Its NADAC has been published 171 times since May 17, 2023.
FDA first approved this application on Aug 26, 2014. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155047342
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
FUROSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203428FDA Approved
8/26/2014
TE Code
AP
On Market Since
9/2/2014
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 40 MG/4 ML VIAL has been published 171 times since May 17, 2023, and over the history we have for it it has declined 22.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2658 per ML |
|---|---|
| All-time high | $0.5940 (Apr 10, 2024) |
| All-time low | $0.2231 (Jun 18, 2025) |
| 52-week high | $0.3500 |
| 52-week low | $0.2231 |
| Median price | $0.3027 |
| Average price | $0.3260 |
| Largest weekly change | +72.8% (Nov 22, 2023) |
| Weeks tracked | 171 |
| Tracking since | May 17, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FUROSEMIDE 40 MG/4 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 40 MG/4 ML VIAL, manufactured by Heritage Pharmaceuticals Inc., is $0.2658 per ML (NDC 23155047342), effective Aug 19, 2026.
How has the price of FUROSEMIDE 40 MG/4 ML VIAL changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 40 MG/4 ML VIAL has declined 22.7%. It has been tracked across 171 weekly CMS publications since May 17, 2023.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 40 MG/4 ML VIAL?
Since May 17, 2023, the NADAC for FUROSEMIDE 40 MG/4 ML VIAL has ranged from a low of $0.2231 (Jun 18, 2025) to a high of $0.5940 (Apr 10, 2024), with a median of $0.3027 per ML.
Are there cheaper alternatives to FUROSEMIDE 40 MG/4 ML VIAL?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FUROSEMIDE 40 MG/4 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures FUROSEMIDE 40 MG/4 ML VIAL?
FUROSEMIDE 40 MG/4 ML VIAL (NDC 23155047342) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.
Is FUROSEMIDE 40 MG/4 ML VIAL in shortage?
Yes — NDC 23155047342 is currently listed in FDA's drug shortage database (posted Apr 7, 2020). Reported reason: Other.